Rose A Lombardo is a Forest Hills, New York based female Ophthalmologist who is specialized in Ophthalmology. Active license number of Rose A Lombardo is 1534551 for Ophthalmology in New York. Rose A Lombardo is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
Rose A Lombardo speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
M.D.
Gender:
Female
Practice Address:
20 Cranford St, Forest Hills, New York, 11375-5918
Phone:
718-263-8512
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1356501597
NPI Enumeration Date:
11 Jun, 2008
NPI Last Update On:
11 Jun, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Rose A Lombardo are as mentioned below.
License Number
Specialization
State
Status
1534551
Ophthalmology
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
20 Cranford St, Forest Hills, New York
Zip:
11375-5918
Phone Number:
718-263-8512
Fax Number:
--
Patients can reach Rose A Lombardo at 20 Cranford St, Forest Hills, New York or can call to book an appointment on 718-263-8512. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.